We evaluated non-smad pathways by examining the phosphorylation of ERK, JNK, p38 and AKT signaling in SMMC-7721 and HCC-LM3 cells in the presence of TGF-β1, which respresents the activation of non-smad pathway. The gene discussed is AKT1; the disease is hepatocellular carcinoma.